Expansile Nanoparticles Encapsulate Factor Quinolinone Inhibitor 1 and Accumulate in Murine Liver upon Intravenous Administration. 2020

Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
MCBB Graduate Program and Department of Biology, Boston University, Boston, Massachusetts 02215, United States.

Expansile nanoparticles (eNPs) are a promising pH-responsive polymeric drug delivery vehicle, as demonstrated in multiple intraperitoneal cancer models. However, previous delivery routes were limited to intraperitoneal injection and to a single agent, paclitaxel. In this study, we preliminarily evaluate the biodistribution and in vivo toxicity of eNPs in mice after intravenous injection. The eNPs localize predominantly to the liver, without detectable acute toxicity in the liver or other key organs. On the basis of these results, we encapsulated FQI1, a promising lead compound for treatment of hepatocellular carcinoma, in eNPs. eNPs are taken up by cancerous and noncancerous human liver cells in vitro, although at different rates. FQI1-loaded eNPs release FQI1 in a pH-dependent manner and limit proliferation equivalently to unencapsulated FQI1 in immortalized hepatocytes in vitro. eNPs are a versatile platform delivery system for therapeutic compounds and have potential utility in the treatment of liver disease.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle
D061605 Administration, Intravenous Delivery of substances through VENIPUNCTURE into the VEINS. Intravenous Administration,Administrations, Intravenous,Intravenous Administrations

Related Publications

Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
July 2015, Nanomedicine : nanotechnology, biology, and medicine,
Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
January 2011, Biomaterials,
Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
February 2023, ACS nano,
Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
May 2013, Annals of surgical oncology,
Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
December 1995, Journal of pharmaceutical sciences,
Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
April 2011, The Annals of thoracic surgery,
Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
October 1950, Klinische Wochenschrift,
Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
February 2021, International journal of molecular sciences,
Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
January 2014, Morfologiia (Saint Petersburg, Russia),
Patrick Stoiber, and Iriny Ekladious, and Qing Zhao, and Yolonda L Colson, and Scott E Schaus, and Ulla Hansen, and Mark W Grinstaff
November 2014, Marine pollution bulletin,
Copied contents to your clipboard!